Titan Pharma (TTNP) Tops Q1 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to Titan Pharma (TTNP) Tops Q1 EPS by 3c

Titan Pharmaceuticals Reports First Quarter 2016 Financial Results

May 10, 2016 7:01 AM EDT

SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 05/10/16 -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a specialty pharmaceutical company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura" long-term, continuous drug delivery platform, today reported financial results for the first quarter ended March 31, 2016.

Titan reported no license revenue for the first quarter of 2016, compared with approximately $0.9 million for the comparable period in 2015. License revenue in the first quarter of 2015 reflected the amortization of the upfront license fee received from commercialization and development partner... More